January 12, 2018 / 10:30 AM / a year ago

BRIEF-Shanghai Shyndec Pharmaceutical unit receives GMP certificate

Jan 12 (Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd

* Says Shantou-based pharmaceutical unit received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration and the valid period is until Jan. 3, 2023

* Certificate issued to unit’s products including troche, hard capsule and granula

Source text in Chinese:goo.gl/zfLxSe

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below